Libra Infusions Limited (DSE:LIBRAINFU)

Market Cap	1.79B
Revenue (ttm)	197.03M
Net Income (ttm)	1.58M
Shares Out	2.25M
EPS (ttm)	0.70
PE Ratio	1,129.60
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	n/a

Volume	2,748
Average Volume	6,322
Open	n/a
Previous Close	790.00
Day's Range	790.10 - 800.00
52-Week Range	611.00 - 1,125.00
Beta	-0.14
RSI	41.08
Earnings Date	n/a

About Libra Infusions

Libra Infusions Limited manufactures and sells injectable intravenous fluids in Bangladesh. Its products are used in medical situations, including diuresis, surgical intervention, intoxication, sodium deficit, infections, and weakness. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 699
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: LIBRAINFU

Financial Performance

In 2019, Libra Infusions's revenue was 197.03 million, an increase of 3.31% compared to the previous year's 190.72 million. Earnings were 1.58 million, a decrease of -72.49%.